The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels

por Rizos, Christos V., Liberopoulos, Evangelos N., Tellis, Constantinos C., Tselepis, Alexandros D., Elisaf, Moses S.
Publicado 2013

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study

por Filippatos, Theodosios D, Liberopoulos, Evangelos, Georgoula, Maria, Tellis, Constantinos C, Tselepis, Alexandros D, Elisaf, Moses
Publicado 2017

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation

por Dafnis, Ioannis, Tsouka, Aikaterini N., Gkolfinopoulou, Christina, Tellis, Constantinos C., Chroni, Angeliki, Tselepis, Alexandros D.
Publicado 2022

Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen

por Tsiailanis, Antonios D., Tellis, Constantinos C., Papakyriakopoulou, Paraskevi, Kostagianni, Androniki D., Gkalpinos, Vasileios, Chatzigiannis, Christos M., Kostomitsopoulos, Nikolaos, Valsami, Georgia, Tselepis, Alexandros D., Tzakos, Andreas G.
Publicado 2023